Services-Commercial Physical & Biological Research
Standard Industrial Classification: SIC 8731
Industry Insider Sentiment Analysis
The Services-Commercial Physical & Biological Research sector (SIC 8731) acts as a critical barometer for broader economic health. Our real-time monitoring reveals 2483 total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 02:36 | 2026-02-18 | OABI | OmniAb, Inc. | Berkman Charles S | Officer | OPT+S | $1.71 | 9,673 | $16,541 | 392,700 |
| 2026-02-19 02:35 | 2026-02-18 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | OPT+S | $1.71 | 9,301 | $15,905 | 268,851 |
| 2026-02-19 02:34 | 2026-02-18 | OABI | OmniAb, Inc. | FOEHR MATTHEW W | Director, Officer | OPT+S | $1.71 | 30,843 | $52,742 | 4,403,277 |
| 2026-02-18 02:22 | 2026-02-17 | OABI | OmniAb, Inc. | FOEHR MATTHEW W | Director, Officer | OPT+S | $1.70 | 20,754 | $35,282 | 4,375,787 |
| 2026-02-18 02:20 | 2026-02-17 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | OPT+S | $1.70 | 6,828 | $11,608 | 259,402 |
| 2026-02-18 02:18 | 2026-02-17 | OABI | OmniAb, Inc. | Berkman Charles S | Officer | OPT+S | $1.70 | 6,990 | $11,883 | 383,623 |
| 2026-02-05 00:52 | 2026-02-02 | ABSI | Absci Corp | McClain Sean | Director, Officer | SELL | $2.99 | 26,761 | $80,015 | 8,334,567 |
| 2026-02-05 00:51 | 2026-02-02 | ABSI | Absci Corp | Jonasson Zachariah | Officer | SELL | $2.99 | 17,496 | $52,313 | 383,538 |
| 2026-02-04 00:14 | 2026-02-02 | NOTV | Inotiv, Inc. | Leasure Robert Jr. | Director, Officer | SELL | $0.50 | 113,297 | $57,034 | 1,273,025 |
| 2026-01-20 16:49 | 2025-08-22 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | LaPlume Joseph W | Officer | SELL | $163.72 | 400 | $65,488 | 23,716 |
| 2026-01-09 00:03 | 2026-01-07 | INCY | INCYTE CORP | Issa Mohamed Khairie | Officer | SELL | $109.07 | 10,856 | $1,184,064 | 66,132 |
| 2026-01-08 00:03 | 2026-01-05 | INCY | INCYTE CORP | Stein Steven H | Officer | SELL | $101.70 | 15,634 | $1,589,978 | 34,203 |
| 2025-12-24 04:00 | 2025-10-22 | ONMD | OneMedNet Corp | Green Aaron | Director, Officer | SELL | $1.73 | 126,322 | $218,625 | 1,804,103 |
| 2025-12-23 04:46 | 2025-12-18 | INCY | INCYTE CORP | Tray Thomas | Officer | OPT+S | $99.69 | 3,374 | $336,350 | 22,973 |
| 2025-12-20 01:00 | 2025-12-18 | IQV | IQVIA HOLDINGS INC. | BOUSBIB ARI | Director, Officer | OPT+S | $222.43 | 36,564 | $8,132,931 | 820,599 |
| 2025-12-19 00:11 | 2025-12-16 | INCY | INCYTE CORP | Morrissey Michael James | Officer | SELL | $97.29 | 58,331 | $5,675,000 | 27,507 |
| 2025-12-13 00:01 | 2025-12-10 | INCY | INCYTE CORP | Mayes Patrick A | Officer | SELL | $95.55 | 5,808 | $554,965 | 60,011 |
| 2025-12-10 00:04 | 2025-12-05 | ABSI | Absci Corp | VAN HOUTEN FRANS | Director | BUY | $3.72 | 40,000 | $148,800 | 63,320 |
| 2025-12-09 17:02 | 2025-12-08 | OABI | OmniAb, Inc. | Berkman Charles S | Officer | OPT+S | $1.96 | 8,044 | $15,766 | 377,071 |
| 2025-12-09 17:02 | 2025-12-08 | OABI | OmniAb, Inc. | GUSTAFSON KURT A | Officer | OPT+S | $1.96 | 23,922 | $46,887 | 252,688 |
| 2025-12-09 17:01 | 2025-12-08 | OABI | OmniAb, Inc. | FOEHR MATTHEW W | Director, Officer | OPT+S | $1.96 | 13,666 | $26,785 | 4,360,083 |
| 2025-12-05 00:26 | 2025-12-03 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $590.69 | 668 | $394,581 | 646,184 |
| 2025-12-04 00:36 | 2025-12-01 | INCY | INCYTE CORP | Stein Steven H | Officer | SELL | $102.56 | 22,664 | $2,324,438 | 63,129 |
| 2025-12-04 00:28 | 2025-12-01 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $592.70 | 28,876 | $17,114,846 | 646,852 |
| 2025-12-03 00:41 | 2025-12-01 | NOTV | Inotiv, Inc. | Neff R Matthew | Director | SELL | $0.89 | 2,000 | $1,771 | 151,102 |
| 2025-12-02 00:48 | 2025-11-26 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $603.28 | 56,482 | $34,074,472 | 675,728 |
| 2025-11-27 05:56 | 2025-06-20 | ONMD | OneMedNet Corp | Yu Jeffrey | Director, Officer | BUY | $0.48 | 2,010,479 | $959,602 | 7,081,223 |
| 2025-11-27 05:55 | 2024-02-01 | ONMD | OneMedNet Corp | Yu Jeffrey | Director, Officer | BUY | $0.94 | 9,540 | $8,928 | 2,763,195 |
| 2025-11-27 05:54 | 2023-12-07 | ONMD | OneMedNet Corp | Golden Robert Lawrence | Director, Officer | BUY | $1.71 | 300 | $513 | 300 |
| 2025-11-27 05:54 | 2025-04-21 | ONMD | OneMedNet Corp | Kosasa Thomas | Director | BUY | $0.56 | 1,879,871 | $1,049,532 | 15,740,191 |
| 2025-11-27 05:54 | 2024-02-16 | ONMD | OneMedNet Corp | Casaburi Eric | Director | BUY | $1.92 | 20,475 | $39,263 | 65,475 |
| 2025-11-27 05:54 | 2023-12-08 | ONMD | OneMedNet Corp | Yu Jeffrey | Director, Officer | BUY | $0.76 | 22,762 | $17,192 | 2,522,886 |
| 2025-11-27 00:29 | 2025-11-24 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $611.02 | 101,417 | $61,967,339 | 732,210 |
| 2025-11-27 00:22 | 2025-11-24 | MEDP | Medpace Holdings, Inc. | BURWIG SUSAN E | Officer | SELL | $609.15 | 20,000 | $12,183,000 | 27,500 |
| 2025-11-26 00:40 | 2025-11-21 | MEDP | Medpace Holdings, Inc. | Brady Kevin M. | Officer | OPT+S | $590.35 | 3,000 | $1,771,050 | 6,000 |
| 2025-11-26 00:02 | 2025-11-21 | INCY | INCYTE CORP | Tray Thomas | Officer | SELL | $102.78 | 769 | $79,038 | 23,573 |
| 2025-11-25 00:20 | 2025-11-20 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $593.68 | 28,688 | $17,031,558 | 833,627 |
| 2025-11-21 00:14 | 2025-11-18 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $591.79 | 31,053 | $18,376,706 | 862,315 |
| 2025-11-20 00:08 | 2025-11-17 | INCY | INCYTE CORP | Denton Sheila A. | Officer | OPT+S | $104.36 | 278 | $29,012 | 26,569 |
| 2025-11-19 01:02 | 2025-11-14 | MEDP | Medpace Holdings, Inc. | Kraft Robert O. | Director | OPT+S | $591.85 | 6,472 | $3,830,453 | 833 |
| 2025-11-19 00:51 | 2025-11-14 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $594.02 | 20,794 | $12,352,077 | 893,368 |
| 2025-11-15 00:41 | 2025-11-12 | MEDP | Medpace Holdings, Inc. | Troendle August J. | Director, Officer, 10% owner | SELL | $602.32 | 10,440 | $6,288,183 | 914,162 |
| 2025-11-13 00:06 | 2025-11-10 | INCY | INCYTE CORP | Hoppenot Herve | Director | SELL | $105.46 | 187,500 | $19,773,750 | 329,646 |
| 2025-11-12 18:10 | 2025-11-11 | MEDP | Medpace Holdings, Inc. | BURWIG SUSAN E | Officer | SELL | $605.00 | 18,000 | $10,890,000 | 47,500 |
| 2025-11-10 16:30 | 2025-11-06 | OABI | OmniAb, Inc. | HIGGINS JOHN L | Director | BUY | $1.39 | 77,261 | $107,710 | 2,929,148 |
| 2025-11-08 00:38 | 2025-11-05 | MEDP | Medpace Holdings, Inc. | GEIGER JESSE J | Officer | SELL | $595.66 | 21,503 | $12,808,477 | 15,000 |
| 2025-11-08 00:01 | 2025-11-05 | INCY | INCYTE CORP | Stein Steven H | Officer | OPT+S | $102.20 | 5,233 | $534,813 | 102,886 |
| 2025-11-07 00:01 | 2025-11-04 | INCY | INCYTE CORP | Denton Sheila A. | Officer | OPT+S | $101.36 | 598 | $60,613 | 26,569 |
| 2025-11-06 00:12 | 2025-11-03 | INCY | INCYTE CORP | Heeson Lee | Officer | SELL | $94.02 | 3,074 | $289,017 | 29,241 |
| 2025-11-05 01:16 | 2025-11-03 | NOTV | Inotiv, Inc. | Neff R Matthew | Director | SELL | $1.24 | 2,000 | $2,487 | 153,102 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Services-Commercial Physical & Biological Research sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8731) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Services-Commercial Physical & Biological Research
Every transaction in the Services-Commercial Physical & Biological Research industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.